BEATRICE AZAH: Open Payments
NPI 1245099340 · CRANSTON, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$938 in 40 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $133 · 2025 $938
Food & beverage: $938
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 10 | $238 |
| Otsuka America Pharmaceutical, Inc. | 8 | $181 |
| Neurocrine BioSciences, Inc. | 5 | $141 |
| ABBVIE INC. | 6 | $118 |
| Janssen Pharmaceuticals, Inc | 4 | $114 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $93 |
| Supernus Pharmaceuticals, Inc. | 2 | $36 |
| Alkermes, Inc. | 1 | $18 |
Products named: INGREZZA, REXULTI, COBENFY, VRAYLAR, CAPLYTA, SPRAVATO, ABILIFY ASIMTUFII, INVEGA SUSTENNA.
Industry payments across RI — which companies pay providers there.
